Jiangsu Sinopep-Allsino Biopharmaceutical Co., Ltd.

The company is a biomedical enterprise focusing on polypeptide drugs and small molecule chemicals, combining independent research and development with customized research and development. The company is a national high-tech enterprise and a provincial science and technology enterprise. It was founded in April 2009 and is located in the national Lianyungang Economic and Technological Development Zone. The company was listed on the Science and Technology Innovation Board of the Shanghai Stock Exchange on May 20, 2021. The company is a biomedical enterprise focusing on the combination of independent research and development of polypeptide drugs and small molecule chemicals with customized R&D and production. The company's main products are self-selected products, customized products and technical services.